German health insurance fund removes medical cannabis: allegations of conflict of interest

The German health insurance fund recently decided to no longer cover medical cannabis. This step has raised questions among various parties about the motives behind the decision. According to CNNBS.nl, there are indications that there may be a conflict of interest.

Medical cannabis is recognized as a treatment for certain medical conditions in some countries. The removal of coverage means that patients who use the drug will now have to pay the costs themselves. How this decision was made is still unclear.

The source reports that there is discussion about possible influence from pharmaceutical companies or other stakeholders. Concrete evidence is still lacking, but the decision does raise questions about transparency within the German healthcare system. Whether a formal investigation will follow is not yet known.

This report is a summary based on the mentioned source and is not medical advice. Always consult a doctor or pharmacist in case of complaints.